EHA 2023: Chemo-Free Regimen Shows 10-Year Survival Advantage for Patients With Acute Promyelocytic Leukemia
Benefits of all-trans retinoic acid + arsenic trioxide seen irrespective of the Sanz-risk score
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.